These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 25534392)

  • 1. Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective.
    Singh V; Badheka AO; Patel NJ; Chothani A; Mehta K; Arora S; Patel N; Deshmukh A; Shah N; Savani GT; Rathod A; Manvar S; Thakkar B; Panchal V; Patel J; Palacios IF; Rihal CS; Cohen MG; O'Neill W; De Marchena E
    Catheter Cardiovasc Interv; 2015 May; 85(6):1073-81. PubMed ID: 25534392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
    Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
    Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hospital volume on outcomes of percutaneous ASD/PFO closure in pediatric patients.
    Bhatt P; Patel A; Kumar V; Lekshminarayanan A; Patel V; Alapati S; Billimoria ZC
    World J Pediatr; 2018 Aug; 14(4):364-372. PubMed ID: 29508364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracardiac echocardiography during atrial septal defect and patent foramen ovale device closure in pediatric and adolescent patients.
    Medford BA; Taggart NW; Cabalka AK; Cetta F; Reeder GS; Hagler DJ; Johnson JN
    J Am Soc Echocardiogr; 2014 Sep; 27(9):984-90. PubMed ID: 24998516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
    Manolis AS
    Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M; Mullen M
    Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.
    Abaci A; Unlu S; Alsancak Y; Kaya U; Sezenoz B
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1123-38. PubMed ID: 23412921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation.
    Loar RW; Johnson JN; Cabalka AK; Cetta F; Hagler DJ; Eidem BW; Taggart NW
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1234-7. PubMed ID: 23239614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
    Van de Bruaene A; Stroobants D; Benit E
    Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial septal defect and patent foramen ovale: early and long-term effects on endothelial function after percutaneous occlusion procedure.
    Scicchitano P; Gesualdo M; Cortese F; Acquaviva T; de Cillis E; Bortone AS; Ciccone MM
    Heart Vessels; 2019 Sep; 34(9):1499-1508. PubMed ID: 30895384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure.
    Johnson JN; Marquardt ML; Ackerman MJ; Asirvatham SJ; Reeder GS; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):254-61. PubMed ID: 21563292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
    Thompson AJ; Hagler DJ; Taggart NW
    Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume.
    Badheka AO; Chothani A; Mehta K; Patel NJ; Deshmukh A; Hoosien M; Shah N; Singh V; Grover P; Savani GT; Panaich SS; Rathod A; Patel N; Arora S; Bhalara V; Coffey JO; O'Neill W; Makkar R; Grines CL; Schreiber T; Di Biase L; Natale A; Viles-Gonzalez JF
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):42-8. PubMed ID: 25480543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malattached septum primum and deficient septal rim predict unsuccessful transcatheter closure of atrial communications.
    Ostermayer SH; Srivastava S; Doucette JT; Ko HH; Geiger M; Parness IA; Love BA
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1195-203. PubMed ID: 26332722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "One-stop shop": safety and efficacy of combining atrial septal defect occlusion and left atrial appendage closure for patients with atrial septal defect and atrial fibrillation.
    Zhang ZH; Yao Q; Huang HY; Zhu P; Xu X; Song ZY; Li HK
    BMC Cardiovasc Disord; 2020 Oct; 20(1):444. PubMed ID: 33045999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent foramen ovale closure without echocardiographic control: use of "standby" intracardiac ultrasound.
    Hildick-Smith D; Behan M; Haworth P; Rana B; Thomas M
    JACC Cardiovasc Interv; 2008 Aug; 1(4):387-91. PubMed ID: 19463334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
    Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
    Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous closure of patent foramen ovale and atrial septal defect: procedure outcome and medium-term follow-up.
    Egred M; Andron M; Albouaini K; Alahmar A; Grainger R; Morrison WL
    J Interv Cardiol; 2007 Oct; 20(5):395-401. PubMed ID: 17880337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
    Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
    J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.